Bridge to Life, Ltd. has received FDA 510(k) clearance for its innovative organ preservation solutions, expanding access for abdominal organs and enhancing transplantation technology.

TYBR Health has received FDA 510(k) clearance for its B3 GEL™, a bioresorbable gel designed to protect healing tissues and support surgical recovery, promising enhanced patient outcomes.

AliveDx has taken a significant step by submitting a 510(k) premarket notification to the FDA for its innovative multiplex biochip MosaiQ AiPlex® CTDplus. This technology aims to improve autoimmune disease diagnostics.

AliveDx has announced the submission of a 510(k) premarket notification to the FDA for its groundbreaking MosaiQ AiPlex CTDplus multiplex microarray, aimed at improving autoimmune disease diagnoses.